• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺分化过程中的染色质以及CD4、CD8A和CD8B基因表达。

Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation.

作者信息

Kioussis Dimitris, Ellmeier Wilfried

机构信息

Division of Molecular Immunology, National Institute for Medical Research, The Ridgeway, London NW7 1AA, UK.

出版信息

Nat Rev Immunol. 2002 Dec;2(12):909-19. doi: 10.1038/nri952.

DOI:10.1038/nri952
PMID:12461564
Abstract

The regulation of gene expression during thymocyte development provides an ideal experimental system to study lineage-commitment processes. In particular, expression of the CD4, CD8A and CD8B genes seems to correlate well with the cell-fate decisions that are taken by thymocytes, and elucidating the molecular mechanisms that underlie the differential expression of these genes could reveal key events in differentiation processes. Here, we review examples of how gene cis elements (such as promoters, enhancers and locus control regions) and trans elements (such as transcription factors, chromatin-remodelling complexes and histone-modification enzymes) come together to orchestrate a finely tuned sequence of events that results in the complex pattern of CD4, CD8A and CD8B gene expression that is observed during thymocyte development.

摘要

胸腺细胞发育过程中的基因表达调控为研究细胞谱系定向过程提供了一个理想的实验系统。特别是,CD4、CD8A和CD8B基因的表达似乎与胸腺细胞所做出的细胞命运决定密切相关,阐明这些基因差异表达背后的分子机制可能会揭示分化过程中的关键事件。在这里,我们回顾了基因顺式元件(如启动子、增强子和基因座控制区)和反式元件(如转录因子、染色质重塑复合物和组蛋白修饰酶)如何共同作用,精心编排一系列精确调控的事件,从而导致在胸腺细胞发育过程中观察到的CD4、CD8A和CD8B基因表达的复杂模式。

相似文献

1
Chromatin and CD4, CD8A and CD8B gene expression during thymic differentiation.胸腺分化过程中的染色质以及CD4、CD8A和CD8B基因表达。
Nat Rev Immunol. 2002 Dec;2(12):909-19. doi: 10.1038/nri952.
2
Biochemical and functional analyses of chromatin changes at the TCR-beta gene locus during CD4-CD8- to CD4+CD8+ thymocyte differentiation.CD4-CD8-至CD4+CD8+胸腺细胞分化过程中TCR-β基因座染色质变化的生化与功能分析。
J Immunol. 1998 Feb 1;160(3):1256-67.
3
Pre-TCR signaling and CD8 gene bivalent chromatin resolution during thymocyte development.胸腺细胞发育过程中的 pre-TCR 信号和 CD8 基因二价染色质解析。
J Immunol. 2011 Jun 1;186(11):6368-77. doi: 10.4049/jimmunol.1003567. Epub 2011 Apr 22.
4
Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.SWI/SNF样BAF复合物对CD4/CD8表达的相互调节。
Nature. 2002 Jul 11;418(6894):195-9. doi: 10.1038/nature00876.
5
Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate.ThPOK通过级联抑制转录沉默子来锁定辅助性T细胞命运。
Nat Immunol. 2008 Oct;9(10):1113-21. doi: 10.1038/ni.1650. Epub 2008 Sep 7.
6
Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.解开一个具有启发性的悖论:为何在CD8⁺ T细胞阳性选择过程中,主要组织相容性复合体I信号传导的胸腺细胞“看似矛盾地”呈现为CD4⁺8低表达的过渡细胞。
J Exp Med. 2003 Jun 16;197(12):1709-19. doi: 10.1084/jem.20030170.
7
Promoter knock-in mutations reveal a role of Mcl-1 in thymocyte-positive selection and tissue or cell lineage-specific regulation of Mcl-1 expression.启动子敲入突变揭示了Mcl-1在胸腺细胞阳性选择以及Mcl-1表达的组织或细胞谱系特异性调控中的作用。
J Immunol. 2009 Mar 1;182(5):2959-68. doi: 10.4049/jimmunol.0803550.
8
Regulation of chromatin structure during thymic T cell development.胸腺T细胞发育过程中染色质结构的调控。
J Cell Biochem. 2005 Jun 1;95(3):466-77. doi: 10.1002/jcb.20391.
9
CD8 locus nuclear dynamics during thymocyte development.CD8 基因座核动态在胸腺细胞发育过程中的作用。
J Immunol. 2010 May 15;184(10):5686-95. doi: 10.4049/jimmunol.1000170. Epub 2010 Apr 19.
10
Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.Runx蛋白在CD8胸腺细胞分化过程中对重新激活CD8和沉默CD4的双重作用。
Immunity. 2005 Mar;22(3):317-28. doi: 10.1016/j.immuni.2005.01.012.

引用本文的文献

1
UHRF1 in Immune Regulation and Diseases: Mechanisms and Therapeutic Implications.UHRF1在免疫调节与疾病中的作用:机制及治疗意义
Clin Rev Allergy Immunol. 2025 Jul 22;68(1):68. doi: 10.1007/s12016-025-09079-6.
2
Genetic diversity and regulatory features of human-specific duplications.人类特异性重复序列的遗传多样性和调控特征
bioRxiv. 2025 Mar 17:2025.03.14.643395. doi: 10.1101/2025.03.14.643395.
3
Combined transcriptome and metabolome analysis of stable knockdown and overexpression of the CD8A gene in chicken T lymphocytes.
鸡T淋巴细胞中CD8A基因稳定敲低和过表达的转录组与代谢组联合分析
Poult Sci. 2025 Feb;104(2):104686. doi: 10.1016/j.psj.2024.104686. Epub 2024 Dec 17.
4
Exploring personalized treatment for cardiac graft rejection based on a four-archetype analysis model and bioinformatics analysis.基于四原型分析模型和生物信息学分析探索心脏移植物排斥的个性化治疗。
Sci Rep. 2024 Mar 19;14(1):6529. doi: 10.1038/s41598-024-57097-9.
5
Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis.肝细胞癌中细胞铁死亡与免疫之间的潜在关联及其与预后的关系分析
Front Oncol. 2023 Jan 12;12:1031156. doi: 10.3389/fonc.2022.1031156. eCollection 2022.
6
Increased CD4CD8 Double Positive T Cells during Hantaan Virus Infection.汉坦病毒感染期间 CD4CD8 双阳性 T 细胞增加。
Viruses. 2022 Oct 13;14(10):2243. doi: 10.3390/v14102243.
7
TOX Expression in Mycosis Fungoides and Sezary Syndrome.蕈样肉芽肿和塞扎里综合征中的TOX表达
Diagnostics (Basel). 2022 Jun 29;12(7):1582. doi: 10.3390/diagnostics12071582.
8
A novel four-gene signature predicts immunotherapy response of patients with different cancers.一种新型的四基因标志物可预测不同癌症患者的免疫治疗反应。
J Clin Lab Anal. 2022 Jul;36(7):e24494. doi: 10.1002/jcla.24494. Epub 2022 May 19.
9
Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.基于加权相关网络分析鉴定黑色素瘤抗 PD-1 治疗的潜在生物标志物
Genes (Basel). 2020 Apr 17;11(4):435. doi: 10.3390/genes11040435.
10
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.从低级别胶质瘤外显子组文件中恢复 T 细胞受体 V(D)J 重组读取与降低的存活率和较高的癌症分级相关。
J Neurooncol. 2018 Dec;140(3):697-704. doi: 10.1007/s11060-018-03001-1. Epub 2018 Oct 31.